Experiment.com Gains Big Venture Backers To Bring Crowdfunding To Science
blogs.wsj.com
blogs.wsj.com
Edit: I'm getting an error when trying to signup with FB:
"The change you wanted was rejected.
Maybe you tried to change something you didn't have access to."
We've been working on a site that helps connect science projects with skilled (volunteer) developers. We're about ready to launch to the general public, and would absolutely love to connect and discuss how we can help each other out if you're interested.
Please drop me an email at davedx@gmail.com
Thanks, and great job!
1. At the moment, the people posting projects are mostly PhD students. This is excellent for PhD students, but the real challenge is getting more entrenched scientists to explore this new medium. I've seen a few professors, but not many. I'd love to know how Experiment are planning to engage the science community.
2. Currently it's only open to US scientists. This really sucks for the rest of us. A major potential benefit of this platform is to open up science to those in places where science funding is really bad, unlike the US where it's just not as good as it used to be, but is still tens of billions per year. Please fix this.
It is on the other hand great to let a PhD student get some funding for their work, pay for a field visit, etc. Crowd funding is a supplement to internal grants and pilot grants at this point, not the NIH/NSF lifeblood of most labs.
Could crowdfunding get so much more bang for the buck, as compared with traditional funding?
Edit: To answer my own question, funds are currently not subject to university overhead according to their FAQ.
That's what I meant by more trouble than it's worth. A staff member going "meh" can turn into a huge time sink.
This is not how much money goes to the university. The university negotiates an overhead rate, which gets tacked onto the cost. This can often be more than half the cost of the grant. This helps cover indirect costs - the costs of administrative staff, copier paper, computing infrastructure, startup funds for new faculty, etc.
"More bang for the buck" assumes the researcher would get that overhead back for their own use. What actually happens is researchers get the same direct costs, the overhead % is zero, etc.
For minor grants, like where crowd funding is now, this isn't such a big deal. But if this somehow became the dominant paradigm, the overhead costs are going to have to come from somewhere...
Kickstarter seems geared towards the music, arts or engineering with clear visual impact. Most science does not have elevator pitches -- they are hard to explain or visualize, and they deal with unsexy issues.
Einstein said if you can't explain a theory to a 5 year old you don't understand it. Is that even really true?
I doubt you can explain the technical details of web apps to the typical 5-year old. Perhaps that is just a defect of our current explanations?
I think scientists just need more practice.
I asked "How much are you trying to raise?"
"Oh, about $300 million."
I had to rehinge my jaw.
Apparently physical labs are expensive.
This is just one second hand data point. Does anyone else have experience in this space? Are setting up labs and development/manufacturing environments for relatively early stage bio companies really this expensive?
At that stage, you are dealing with things like FDA GMP compliance[1] and then actually putting molecules into humans and monitoring them for several efficacy end points as well as toxicity. And often you are doing this at multiple sites.
If the doctor wasn't looking to do trials, then he was being ripped off. And if he wasn't looking to do trials for a major disease, he was also being ripped off. Trials for orphan diseases are often cheaper because they are limited by the number of people who even have the disease.
Also, with the rise of CROs[2], you can often find one that will "risk-share". The CRO will lower your bill, often significantly, in exchange for some of the upside on the molecule.
[1] http://en.wikipedia.org/wiki/Good_manufacturing_practice [2] http://en.wikipedia.org/wiki/Contract_research_organization
It seemed to me from the discussion that he was beyond the exploratory phase and had a very specific drug that needed to go to the next stage.
In oncology, once you have a molecule lead, you should be able to do preclinical in 200k or so if you really pinch the purse. Typically clinicals will run you on the order of $20 million, not 300.
http://lawrencevilleplasmaphysics.com/index.php?option=com_l...
I would like to clarify a couple of instant worries
- ethics committees ? Who runs the ethics committee? Is it public which ones they reject ? UHauling dinos is one thing but bio-ethics will get messy fast.
- peer reviewing - if I invest I want to know the output is a success - is there a systemised approach for this? must they publish to get final drawdown? it's not really an in estment as the usual measure that you did not stuff up your last experiment is that a grant committee finds you again
Every grants office I've talked to has essentially responded with "Wait, what?", and the amounts are small enough that it's often not worth the administrative hassle.
Good luck, seems like a good idea :)
Edit: Found a typo: "research funded ourside of the traditional science funding system" ... should (probably) be outside
Thanks for pointing out the typo, should be fixed!